future glp-1 drugs Antagonists Increase Plan Drug Spend - What's Next Dozens of new obesity drugs

Lincoff AM, et al

however, heart failure with reduced ejection fraction also has a regional cause

This hormone helps to regulate blood sugar levels and gives you a feeling of fullness after you eat

Clinical guidelines are expanding to recommend GLP-1 therapies for this group, supported by evidence showing effective weight loss and metabolic benefits at this stage

Ive really only mentioned the biggest con of GLP-1 agonists which is a potential risk of thyroid cancer but there are others to consider such as muscle loss as well

For dichotomous outcomes, we calculated ORs and 95% CIs using the random-effects MantelHaenszel approach